VOYG · Voyager Technologies, Inc.

The thesis

Voyager Technologies' order book and new defense contracts still back its $275–305 million 2026 revenue guide, but the shares closed at $23.82 on 22 October 2026, 54.0% below the 52-week high of $51.77. The third-quarter report after the close on 2 November 2026 decides whether revenue is converting the backlog.

The narrative is maturing: the story is well known and the price has kept falling since the 9 October 2026 close of $27.26, despite NASA releasing its final commercial space-station request on 9 October 2026. The 22 October 2026 close is below the $24 level that the earlier note set as the end of the recovery case, so that case has failed. The shares fell 9.3% over three months, and their 14-day relative strength index (RSI), a momentum gauge where readings under 30 mark heavily sold shares, stood at 17.3 on 22 October 2026.

Analysts are split. TD Cowen kept a Buy rating and cut its target to $36 on 9 October 2026. Morgan Stanley kept an Underweight rating and cut its target to $36 on 19 October 2026. Both targets sit above the last close.

Bullish and bearish views on Voyager Technologies, Inc.

The bull case on Voyager Technologies, Inc. (VOYG), in brief: Backlog supports the guide. The bear case: The price keeps falling through good news.

Bull case

• Backlog supports the guide. Voyager reported $113.0 million of second-quarter bookings and $335.5 million of backlog on 3 August 2026, and raised 2026 revenue guidance to $275–305 million. The 2 November 2026 report shows whether sales are following the orders.
• NASA's procurement has started. NASA released the final request for proposals on 9 October 2026, with proposals due 8 December 2026 and awards expected in spring 2027. The request guarantees $100 million in minimum orders and caps orders at $34.063 billion across all contracts, according to New Space Economy. Starlab, in which Voyager participates through a joint venture, is a candidate; a request is not an award.
• Defense work is widening. On 29 September 2026 Voyager formalised a partnership with Anduril Industries and is contracted to supply more than $60 million of technologies, according to the companies. On 5 October 2026 it announced a $22.4 million Other Transaction Agreement from the Pentagon's Strategic Capabilities Office.
• Griffin-1 is passing tests. The company reported on 13 October 2026 that the Griffin-1 lunar lander completed acceptance testing, on 20 October 2026 that it finished environmental testing, and on 21 October 2026 that it was selected to carry the HPE Spaceborne Computer-4. The company still targets a launch in late 2026.

Bear case

• The price keeps falling through good news. The shares closed at $27.26 on 9 October 2026 and $23.82 on 22 October 2026, a period that included the NASA request, the lander milestones and a space-sector earnings print from SpaceX that Benzinga said sector peers coasted through on 20 October 2026. The RSI of 17.3 shows heavy selling, and such readings can persist.
• Targets are falling. Morgan Stanley's Underweight rating came with a cut to $36 on 19 October 2026, and TD Cowen cut to $36 from $42 on 9 October 2026 (per TipRanks for the earlier figure).
• Financing adds claims on the shares. Voyager priced $350.0 million of 0% convertible senior notes due 2032 on 23 September 2026, with an initial conversion price near $40.82. It also filed a mixed shelf registration on 14 August 2026, size undisclosed. The conversion price is far above the last close, so dilution from the notes is not near-term.
• Profit conversion is unshown. The second-quarter report recorded an 8.4% gross margin and a $37.5 million adjusted loss before interest, taxes, depreciation and amortization. The NASA award is also months away, so the Starlab payoff is not in 2026 results.

Price setup

The shares closed at $23.82 on 22 October 2026, 54.0% below the 52-week high of $51.77. The close of $31.35 on 25 September 2026, the close of $27.26 on 9 October 2026 and the 22 October 2026 close mark a steady decline of roughly four weeks. Adjusted daily closes show no recovery attempt since the 25 September 2026 level.

The RSI of 17.3 on 22 October 2026 was lower than the 21.0 reading on 9 October 2026. A close back above $27.26 would be the first sign the decline has paused. Crowding evidence is limited to the earnings date: the report falls on 2 November 2026, and the company has the convertible notes and an open shelf registration, which can add shares. No insider transactions or filings are listed for the past 30 days.

Catalysts, next 30 days

• 8 December 2026 (later): proposals due on NASA's final request. Included because the Starlab case turns on the award expected in spring 2027.
• Late 2026 (company target): Griffin-1 launch. Date not confirmed.

Elapsed catalysts

• 2 November 2026: third-quarter results after the close. Revenue, bookings, backlog and gross margin against the $275–305 million guide. (passed 4d ago)
• 3 November 2026: conference call at 9 a.m. ET. Management comments on Starlab bid plans and Griffin-1 timing. (passed 3d ago)

What would change the view

The case breaks if the 2 November 2026 report cuts the $275–305 million revenue guide, or shows gross margin still near the second-quarter 8.4% while backlog stalls. A daily close below $21 would also end it. NASA delaying the 8 December 2026 proposal deadline again, or an award list that omits Starlab, would break the procurement part of the case.

A report that holds the guide, lifts gross margin and shows backlog above $335.5 million would be new evidence for the recovery case; the price would need to close back above $27.26 for the market to confirm it.

What it trades with

Voyager trades with other listed Space economy names, which on 20 October 2026 moved little on SpaceX's third-quarter results (Benzinga), and with defense contractors through its propulsion and Anduril work. Its Starlab outcome depends on NASA budget and procurement decisions, which move independently of the broad market. The convertible notes and shelf registration tie the shares to equity-market conditions for small-cap growth companies.